Millennium to Webcast Conference Call on First Quarter 2001 Financial Results on April 18, 2001

Apr 11, 2001, 01:00 ET from Millennium Pharmaceuticals, Inc.

    CAMBRIDGE, Mass., April 11 /PRNewswire/ -- Millennium Pharmaceuticals,
 Inc. (Nasdaq:   MLNM) will host a live webcast of its conference call discussing
 the Company's first quarter 2001 financial results at 9:00 a.m. EDT on
 Wednesday, April 18, 2001. Mark Levin, chairman and chief executive officer,
 and Kevin Starr, chief financial officer, will host the call. Millennium will
 announce its financial results for this period in a press release to be issued
 after market close on Tuesday, April 17, 2001.
     (Photo:  http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
     The press release and the live webcast can be accessed by visiting
 Millennium's website at www.millennium.com under the "Investor Relations" tab.
 Following the webcast, an archived version of the call will be available at
 the same address until May 31, 2001.
 
     Millennium, a leading biopharmaceutical company, applies its comprehensive
 and integrated science and technology platform for the discovery and
 development of breakthrough therapeutic and predictive medicine products, with
 a goal of delivering personalized medicine.  Through the industrialization of
 this gene-to-patient platform, Millennium is also striving to accelerate the
 process of drug discovery and development.  Headquartered in Cambridge,
 Massachusetts, Millennium currently employs more than 1,300 people.
 
     Editor's Note: This release is also available on Millennium's website at:
 http://www.millennium.com
 
 

SOURCE Millennium Pharmaceuticals, Inc.
    CAMBRIDGE, Mass., April 11 /PRNewswire/ -- Millennium Pharmaceuticals,
 Inc. (Nasdaq:   MLNM) will host a live webcast of its conference call discussing
 the Company's first quarter 2001 financial results at 9:00 a.m. EDT on
 Wednesday, April 18, 2001. Mark Levin, chairman and chief executive officer,
 and Kevin Starr, chief financial officer, will host the call. Millennium will
 announce its financial results for this period in a press release to be issued
 after market close on Tuesday, April 17, 2001.
     (Photo:  http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
     The press release and the live webcast can be accessed by visiting
 Millennium's website at www.millennium.com under the "Investor Relations" tab.
 Following the webcast, an archived version of the call will be available at
 the same address until May 31, 2001.
 
     Millennium, a leading biopharmaceutical company, applies its comprehensive
 and integrated science and technology platform for the discovery and
 development of breakthrough therapeutic and predictive medicine products, with
 a goal of delivering personalized medicine.  Through the industrialization of
 this gene-to-patient platform, Millennium is also striving to accelerate the
 process of drug discovery and development.  Headquartered in Cambridge,
 Massachusetts, Millennium currently employs more than 1,300 people.
 
     Editor's Note: This release is also available on Millennium's website at:
 http://www.millennium.com
 
 SOURCE  Millennium Pharmaceuticals, Inc.